Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.

Regenerative medicine - 1 May 2011

Nishimoto Kevin P, Tseng Su-Yi, Lebkowski Jane S, Reddy Anita

Abstract excerpt

AIM: Dendritic cell (DC)-based vaccines are designed to exploit the intrinsic capacity of these highly effective antigen presenting cells to prime and boost antigen-specific T-cell immune responses. Successful development of DC-based vaccines will be dependent on the ability to utilize and harness the full potential of these potent immune stimulatory cells. Recent advances to generate DCs derived from human...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Antigen Presentation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Embryonic Stem Cells

Share to Immunologic Memory

Share to Interleukin-12

Share to Transduction, Genetic

Share to Viral Matrix Proteins

Source

Identifiers

PMID: 21548736
DOI: 10.2217/rme.11.19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.PMID 21548736Read ↗

Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.Semantic proximity Read ↗

Genetically Manipulated Human Embryonic Stem Cell-Derived Dendritic Cells with Immune Regulatory FunctionSemantic proximity Read ↗

Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell linesSemantic proximity Read ↗

Cancer immunotherapy with mRNA‐transfected dendritic cellsSemantic proximity Read ↗

Dendritic cells transfected with adenoviral vectors as vaccines.Semantic proximity Read ↗

Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential.Semantic proximity Read ↗

Efficient generation of human dendritic cells from iPSC by introducing a feeder-free expansion step for hematopoietic progenitorsSemantic proximity Read ↗

Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses.Semantic proximity Read ↗

Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.Semantic proximity Read ↗

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer ImmunotherapySemantic proximity Read ↗

Lentivirally transduced dendritic cells as a tool for cancer immunotherapySemantic proximity Read ↗

Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory MoleculesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.